ReviewOpen heart2022
Transcatheter tricuspid valve intervention techniques and procedural steps for the treatment of tricuspid regurgitation: a review of the literature.
Review in Open heart, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 27 citations in OpenAlex.
- Transcatheter edge-to-edge repair in symptomatic patients with severe tricuspid regurgitation and prior heart valve surgery.JTCVS open · 2026Article
- Prevalence and Impact of Diabetes Mellitus in Patients Undergoing Transcatheter Tricuspid Valve Repair Using the Edge-to-Edge Technique.Anatolian journal of cardiology · 2026Article
- Caval Transcatheter Valve Implantation: An Alternate Transcatheter Approach to the Treatment of Severe Tricuspid Regurgitation.CASE (Philadelphia, Pa.) · 2025Article
- Left atrial pressure and significant tricuspid regurgitation in persistent atrial fibrillation.Frontiers in cardiovascular medicine · 2025Article
- Transcatheter tricuspid valve replacement: will it prevail?Frontiers in cardiovascular medicine · 2025Review
- Early and late outcomes after Cardioband procedure in patients with atrial and non-atrial functional tricuspid regurgitation.Cardiovascular diagnosis and therapy · 2024Article
- Sex Differences Among Patients Undergoing Transcatheter Tricuspid Valve Repair Using the Edge-to-Edge Technique.Journal of cardiovascular development and disease · 2024Article
- Transcatheter Repair of Tricuspid Valve Regurgitation: A Systematic Review.Journal of clinical medicine · 2024Review
- Transcatheter Tricuspid Valve Intervention for the Treatment of Tricuspid Regurgitation with TriClip: All You Need to Know.Heart international · 2024Review
- A multifunctional soft robot for cardiac interventions.Science advances · 2023Article
- Three-Dimensional Transesophageal Echocardiography in Percutaneous Catheter-Based Cardiac Interventions.Journal of clinical medicine · 2023Review
- Feasibility and Efficacy of Transcatheter Tricuspid Valve Repair in Patients with Cardiac Implanted Electrical Devices and Trans-Tricuspid Leads.Journal of clinical medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe tricuspid regurgitation (TR) is an undertreated common pathology associated with significant morbidity and mortality. Classically, surgical repair or valve replacement were the only therapeutic options and are associated with up to 10% postprocedural mortality. Transcatheter tricuspid valve interventions are a novel and effective therapeutic option for the treatment of significant TR. Several devices have been developed with different mechanisms of action. They are classified as annuloplasty devices, replacement devices, caval valve implantation and coaptation devices. In this review, we provide a step-by-step description of the procedural steps and techniques of every device along with video support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.